Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Current Taxes (2021 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Current Taxes for 2 consecutive years, with $3.7 million as the latest value for Q4 2025.

  • Quarterly Current Taxes changed N/A to $3.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Dec 2025, changed N/A year-over-year, with the annual reading at $3.7 million for FY2025, N/A changed from the prior year.
  • Current Taxes hit $3.7 million in Q4 2025 for Integra Lifesciences Holdings, down from $24.8 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $24.8 million in Q3 2021 to a low of $3.7 million in Q4 2025.